Literature DB >> 26531738

Tricuspid and mitral endocarditis due to methicillin-resistant Staphylococcus aureus exhibiting vancomycin-creep phenomenon.

Pranathi Rao Sundaragiri1, Saraschandra Vallabhajosyula2, Toufik Mahfood Haddad3, Dennis J Esterbrooks4.   

Abstract

Right-sided infective endocarditis (RIE) is commonly due to Staphylococcus aureus and often involves the tricuspid valve (TV). A 31-year-old man with prior intravenous drug use presented with substernal pain, cough, dyspnoea and fever. Examination revealed a febrile, tachycardic male with peripheral infective endocarditis stigmata and right-heart failure. Laboratory parameters demonstrated leucocytosis, lactic acidosis and methicillin-resistant S. aureus (MRSA) bacteraemia. Echocardiography demonstrated multiple TV echodensities and chest imaging confirmed septic emboli. The MRSA species demonstrated 'vancomycin-creep', necessitating therapy with daptomycin and ceftaroline. Owing to persistent bacteraemia and septic shock, the patient underwent TV surgery, but continued to have a poor postoperative course with subsequent death. Indications for surgical therapy of RIE are limited to the European guidelines and most data are extrapolated from left-heart disease. MRSA exhibiting vancomycin-creep portends a poorer prognosis and requires aggressive therapy. We advocate the use of ceftaroline salvage therapy with daptomycin, pending further trials. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26531738      PMCID: PMC4654159          DOI: 10.1136/bcr-2015-211974

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Tricuspid valve endocarditis with septic pulmonary emboli in a drug addict.

Authors:  Alexander Weymann; Bastian Schmack; Christian Rosendal; Helmut Rauch; Matthias Karck; Ursula Tochtermann; Gábor Szabó
Journal:  Ann Thorac Cardiovasc Surg       Date:  2012-03-24       Impact factor: 1.520

2.  Active native valve endocarditis: determinants of operative death and late mortality.

Authors:  F Jault; I Gandjbakhch; A Rama; M Nectoux; V Bors; E Vaissier; P Nataf; A Pavie; C Cabrol
Journal:  Ann Thorac Surg       Date:  1997-06       Impact factor: 4.330

Review 3.  Native valve right sided infective endocarditis.

Authors:  Karolina Akinosoglou; Efstratios Apostolakis; Markos Marangos; Geoffrey Pasvol
Journal:  Eur J Intern Med       Date:  2013-01-28       Impact factor: 4.487

Review 4.  The changing face of infective endocarditis.

Authors:  B D Prendergast
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

5.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.

Authors:  David R Murdoch; G Ralph Corey; Bruno Hoen; José M Miró; Vance G Fowler; Arnold S Bayer; Adolf W Karchmer; Lars Olaison; Paul A Pappas; Philippe Moreillon; Stephen T Chambers; Vivian H Chu; Vicenç Falcó; David J Holland; Philip Jones; John L Klein; Nigel J Raymond; Kerry M Read; Marie Francoise Tripodi; Riccardo Utili; Andrew Wang; Christopher W Woods; Christopher H Cabell
Journal:  Arch Intern Med       Date:  2009-03-09

6.  Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Authors:  Gilbert Habib; Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Müller; Christoph K Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

Review 7.  Current best practices and guidelines indications for surgical intervention in infective endocarditis.

Authors:  Lars Olaison; Gösta Pettersson
Journal:  Infect Dis Clin North Am       Date:  2002-06       Impact factor: 5.982

Review 8.  What's new in the treatment of serious MRSA infection?

Authors:  Natasha E Holmes; Benjamin P Howden
Journal:  Curr Opin Infect Dis       Date:  2014-12       Impact factor: 4.915

9.  The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA.

Authors:  Katie E Barber; Brian J Werth; Michael J Rybak
Journal:  J Antimicrob Chemother       Date:  2014-09-22       Impact factor: 5.790

10.  Daptomycin Failure for Treatment of Pulmonary Septic Emboli in Native Tricuspid and Mitral Valve Methicillin-Resistant Staphylococcus aureus Endocarditis.

Authors:  Hadeel Zainah; Marcus Zervos; Wassim Stephane; Sara Chamas Alhelo; Ghattas Alkhoury; Allison Weinmann
Journal:  Case Rep Infect Dis       Date:  2013-11-25
View more
  3 in total

1.  An Unusual Occurrence of Methicillin Resistant Staphylococcal Endocarditis with Vancomycin Creep Phenomenon - A Therapeutic Challenge.

Authors:  S Sneha; Shanthan Venishetty; Shubha Seshadri; M Sudhakar Rao; Chiranjay Mukhopadhyay
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 2.  Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic Review.

Authors:  Reese A Cosimi; Nahal Beik; David W Kubiak; Jennifer A Johnson
Journal:  Open Forum Infect Dis       Date:  2017-05-02       Impact factor: 3.835

3.  The role of natriuretic peptides in the management, outcomes and prognosis of sepsis and septic shock.

Authors:  Govind Pandompatam; Kianoush Kashani; Saraschandra Vallabhajosyula
Journal:  Rev Bras Ter Intensiva       Date:  2019-10-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.